Patent · US Active

Pharmaceutical composition, methods for treating and uses thereof

US12263153B2 · kind B2 · utility

0Cited by
79References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2022
Grant dateApr 1, 2025
Priority date
Expiry dateJan 9, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P13/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to methods for treating or preventing chronic kidney disease and cardiovascular disease in patients with chronic kidney disease comprising administering empagliflozin to the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.